Recombinant Human Urokinase/uPA Protein (His Tag) | PKSH033400

(No reviews yet) Write a Review
SKU:
575-PKSH033400
Weight:
1.00 KGS
€641.00
Frequently bought together:

Description

Recombinant Human Urokinase/uPA Protein (His Tag) | PKSH033400 | Gentaur US, UK & Europe Disrtribition

Synonyms: Urokinase-Type Plasminogen Activator; U-Plasminogen Activator; uPA;PLAU;ATF;BDPLT5;QPD;u-PA;UPA;URK

Active Protein: N/A

Activity: Recombinant Human Urokinase-Type Plasminogen Activator is produced by our Mammalian expression system and the target gene encoding Ser21-Leu431 is expressed with a 6His tag at the C-terminus.

Protein Construction: Recombinant Human Urokinase-Type Plasminogen Activator is produced by our Mammalian expression system and the target gene encoding Ser21-Leu431 is expressed with a 6His tag at the C-terminus.

Fusion Tag: C-6His

Species: Human

Expressed Host: Human Cells

Shipping: This product is provided as liquid. It is shipped at frozen temperature with blue ice/gel packs. Upon receipt, store it immediately at<-20°C.

Purity: > 95 % as determined by reducing SDS-PAGE.

Endotoxin: < 1.0 EU per µg as determined by the LAL method.

Stability and Storage: Store at < -20°C, stable for 6 months. Please minimize freeze-thaw cycles.

Molecular Mass: 47.4 kDa

Formulation: Supplied as a 0.2 μm filtered solution of 20mM HEPES, 150mM NaCl, 2mM CaCl, 10% Glycerol, pH 7.5.

Reconstitution: Not Applicable

Background: Recombinant Human Urokinase-Type Plasminogen Activator is a serine protease, which specifically cleaves the zymogen plasminogen to form the active enzyme plasmin. Urokinase-Type Plasminogen Activator is a potent marker of invasion and metastasis in many human cancers associated with breast, colon, stomach, bladder, brain, ovary and endometrium. Human Urokinase-Type Plasminogen Activator is initially synthesized as 431 amino acid precursor with a N-terminal signal peptide residues. The single chain molecule is processed into a disulfide-linked two-chain molecule. There exists two forms A chain, the long A chain contains an EGF-like domain that is responsible for binding of the uPA receptor. The B chain corresponds to the catalytic domain.

Research Area: Cardiovascular, Neuroscience, Cancer, metabolism

View AllClose